Additionally, weight loss is generally seen as having a definitive endpoint, leading users to (rightly or wrongly) expect that their treatment can be tapered down or discontinued once their goal is achieved
Raphael, J., & Shapiro, D
Dosing and Administration Typical dose : 12 mg via subcutaneous injection Onset : Begins within 3060 minutes of administration Duration of action : 612 hours (individual variability may apply) Injection sites : Abdomen, thigh, or other subcutaneous regions Note : Do not exceed one dose in 24 hours
Protocols will vary per person
Your provider specifies the concentration and dose, and you draw the appropriate amount using a syringe
Quality & Purity High-quality GHK-Cu should demonstrate 98% purity by HPLC, with mass spectrometry confirmation of the 401.93 Da molecular weight